We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TASK icon
4051
TaskUs
TASK
$650M
$17K ﹤0.01%
+492
New +$15.5K
TELA icon
4052
TELA Bio
TELA
$36.7M
$17K ﹤0.01%
1,083
+530
+96% +$7.26K
TKC icon
4053
Turkcell
TKC
$4.74B
$17K ﹤0.01%
3,550
+2,513
+242% +$11.8K
VOD icon
4054
Vodafone
VOD
$36.9B
$17K ﹤0.01%
1,000
-14,083
-93% -$264K
VOR icon
4055
Vor Biopharma
VOR
$1.28B
$17K ﹤0.01%
47
+26
+124% +$12.8K
WULF icon
4056
TeraWulf
WULF
$8.42B
$17K ﹤0.01%
882
+582
+194% +$6.21K
XSW icon
4057
State Street SPDR S&P Software & Services ETF
XSW
$498M
$17K ﹤0.01%
100
-2,126
-96% -$346K
IRD
4058
Opus Genetics
IRD
$301M
$17K ﹤0.01%
3,312
+784
+31% +$3.89K
GHL
4059
DELISTED
Greenhill & Co., Inc.
GHL
$17K ﹤0.01%
1,113
-133
-11% -$2.21K
PMGMU
4060
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$17K ﹤0.01%
+1,692
New +$16.9K
CFMS
4061
DELISTED
Conformis, Inc. Common Stock
CFMS
$17K ﹤0.01%
582
+283
+95% +$6.68K
PTR
4062
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$17K ﹤0.01%
341
+246
+259% +$10K
LMPX
4063
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
$17K ﹤0.01%
+1,010
New +$15.1K
STSB
4064
DELISTED
iShares Factors US Small Blend Style ETF
STSB
$17K ﹤0.01%
336
-8,628
-96% -$417K
CCIV.U
4065
DELISTED
Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth
CCIV.U
$17K ﹤0.01%
529
+429
+429% +$10.3K
GTYH
4066
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$17K ﹤0.01%
2,399
-3,095
-56% -$18.8K
AMTX icon
4067
Aemetis
AMTX
$123M
$16K ﹤0.01%
1,434
-16,403
-92% -$259K
ASYS icon
4068
Amtech Systems
ASYS
$264M
$16K ﹤0.01%
1,704
+717
+73% +$7.35K
BBD icon
4069
Banco Bradesco
BBD
$35.2B
$16K ﹤0.01%
3,410
-28,806
-89% -$125K
CFBK icon
4070
CF Bankshares
CFBK
$233M
$16K ﹤0.01%
+806
New +$15.8K
CGC
4071
Canopy Growth
CGC
$426M
$16K ﹤0.01%
68
-1,837
-96% -$470K
CLPR
4072
Clipper Realty
CLPR
$47.2M
$16K ﹤0.01%
2,197
+350
+19% +$2.84K
CODX
4073
Co-Diagnostics
CODX
$5.53M
$16K ﹤0.01%
66
-13
-16% -$3.34K
CPSH icon
4074
CPS Technologies
CPSH
$86.5M
$16K ﹤0.01%
1,697
+1,690
+24,143% +$13.2K
DOCN icon
4075
DigitalOcean
DOCN
$15.1B
$16K ﹤0.01%
+294
New +$12.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.